Portfolio company
Eyevance Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and commercialises prescription ophthalmic products to treat ocular surface diseases for ophthalmologists, optometrists and their patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VISUfarma
This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Oculis
This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.
Iveric Bio
This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.
ISTA Pharmaceuticals
This pharmaceutical company develops and commercialises prescription ophthalmic products to treat eye diseases and allergies for patients and healthcare professionals.
Azura Ophthalmics
This biopharmaceutical company develops ophthalmic keratolytics to treat patients suffering from meibomian gland dysfunction and other ocular surface diseases.
Orasis Pharmaceuticals
This company develops prescription eye drops for adults with age-related blurry near vision.
